Related references
Note: Only part of the references are listed.Ambroxol reverses tau and α-synuclein accumulation in a cholinergic N370S GBA1 mutation model
Shi Yu Yang et al.
HUMAN MOLECULAR GENETICS (2022)
Impaired Sphingolipid Hydrolase Activities in Dementia with Lewy Bodies and Multiple System Atrophy
T. S. Usenko et al.
MOLECULAR NEUROBIOLOGY (2022)
Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease
Matthew Surface et al.
MOVEMENT DISORDERS (2022)
Glucocerebrosidase Activity is not Associated with Parkinson's Disease Risk or Severity
Nurit Omer et al.
MOVEMENT DISORDERS (2022)
Generation of induced pluripotent stem cell line, ICGi034-A, by reprogramming peripheral blood mononuclear cells from a patient with Parkinson's disease associated with GBA mutation
Elena Grigor'eva et al.
STEM CELL RESEARCH (2022)
GBA Variants and Parkinson Disease: Mechanisms and Treatments
Laura Smith et al.
CELLS (2022)
Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations?
Alena E. Kopytova et al.
MOVEMENT DISORDERS (2022)
Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism
A. E. Kopytova et al.
PARKINSONISM & RELATED DISORDERS (2021)
Challenges in the diagnosis of Parkinson's disease
Eduardo Tolosa et al.
LANCET NEUROLOGY (2021)
Glucocerebrosidase activity, cathepsin D and monomeric α-synuclein interactions in a stem cell derived neuronal model of a PD associated GBA1 mutation
Shi-yu Yang et al.
NEUROBIOLOGY OF DISEASE (2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations A Nonrandomized, Noncontrolled Trial
Stephen Mullin et al.
JAMA NEUROLOGY (2020)
Generation of GABAergic striatal neurons by a novel iPSC differentiation protocol enabling scalability and cryopreservation of progenitor cells
Elena Grigor'eva et al.
CYTOTECHNOLOGY (2020)
Second-Generation Pharmacological Chaperones: Beyond Inhibitors
My Lan Tran et al.
MOLECULES (2020)
Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population
A. A. Malakhova et al.
STEM CELL RESEARCH (2020)
Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
C. R. A. Silveira et al.
BMC NEUROLOGY (2019)
SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease
Roy N. Alcalay et al.
MOVEMENT DISORDERS (2019)
Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study
Giulia Polo et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2019)
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies
Silvia Paciotti et al.
CLINICA CHIMICA ACTA (2019)
Mutation analysis of Parkinson's disease genes in a Russian data set
Anton K. Emelyanov et al.
NEUROBIOLOGY OF AGING (2018)
Alpha galactosidase A activity in Parkinson's disease
R. N. Alcalay et al.
NEUROBIOLOGY OF DISEASE (2018)
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease
Farzaneh Atashrazm et al.
SCIENTIFIC REPORTS (2018)
Efficiently Specified Ventral Midbrain Dopamine Neurons from Human Pluripotent Stem Cells Under Xeno-Free Conditions Restore Motor Deficits in Parkinsonian Rodents
Jonathan C. Niclis et al.
STEM CELLS TRANSLATIONAL MEDICINE (2017)
GBA mutations in Gaucher type I Venezuelan patients: ethnic origins and frequencies
Gilberto Gomez et al.
JOURNAL OF GENETICS (2017)
Investigation of novel pharmacological chaperones for Gaucher Disease
Buge Yilmazer et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2017)
Oligomeric α-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson's disease
S. Pchelina et al.
NEUROSCIENCE LETTERS (2017)
A Human Neural Crest Stem Cell-Derived Dopaminergic Neuronal Model Recapitulates Biochemical Abnormalities in GBA1 Mutation Carriers
Shi-Yu Yang et al.
STEM CELL REPORTS (2017)
The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p
Letizia Straniero et al.
SCIENTIFIC REPORTS (2017)
Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease
Laurie A. Robak et al.
BRAIN (2017)
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice
Anna Migdalska-Richards et al.
BRAIN (2017)
Ambroxol effects in glucocerebrosidase and -synuclein transgenic mice
Anna Migdalska-Richards et al.
ANNALS OF NEUROLOGY (2016)
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease
Roberto A. Ortega et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2016)
A New Glucocerebrosidase Chaperone Reduces α-Synuclein and Glycolipid Levels in iPSC-Derived Dopaminergic Neurons from Patients with Gaucher Disease and Parkinsonism
Elma Aflaki et al.
JOURNAL OF NEUROSCIENCE (2016)
Purification of functional human ES and iPSC-derived midbrain dopaminergic progenitors using LRTM1
Bumpei Samata et al.
NATURE COMMUNICATIONS (2016)
ER Stress and Autophagic Per turbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S LEParkinson's iPSC-Derived Dopamine Neurons
Hugo J. R. Fernandes et al.
STEM CELL REPORTS (2016)
Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
Alvaro Sanchez-Martinez et al.
SCIENTIFIC REPORTS (2016)
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations
Roy N. Alcalay et al.
BRAIN (2015)
Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation
Eun-Jin Bae et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
Alisdair McNeill et al.
BRAIN (2014)
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis
David C. Schoendorf et al.
NATURE COMMUNICATIONS (2014)
iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson's Disease
Chris M. Woodard et al.
CELL REPORTS (2014)
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
Matthew E. Gegg et al.
ANNALS OF NEUROLOGY (2012)
Human Embryonic Stem Cell-Derived GABA Neurons Correct Locomotion Deficits in Quinolinic Acid-Lesioned Mice
Lixiang Ma et al.
CELL STEM CELL (2012)
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Sonja Kriks et al.
NATURE (2011)
Decreased Expression of Lysosomal Alpha-Galactosiase A Gene in Sporadic Parkinson's Disease
Guanghua Wu et al.
NEUROCHEMICAL RESEARCH (2011)
Purmorphamine Increases DARPP-32 Differentiation in Human Striatal Neural Stem Cells Through the Hedgehog Pathway
Gehan El-Akabawy et al.
STEM CELLS AND DEVELOPMENT (2011)
Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
Gustavo H. B. Maegawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2009)
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
E. Sidransky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry
X. Kate Zhang et al.
CLINICAL CHEMISTRY (2008)
Decreased activities of lysosomal acid alpha-D-galactosidase A in the leukocytes of sporadic Parkinson's disease
Guanghua Wu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data
Jan Hellemans et al.
GENOME BIOLOGY (2007)
Share Paper
